CRISPR Technology to Cure Sickle Cell Disease at University of Illinois Chicago
January 21, 2021
January 21, 2021
CHICAGO, Illinois, Jan. 21 (TNSJou) -- The University of Illinois Chicago campus issued the following news release:
University of Illinois Chicago is one of the U.S. sites participating in clinical trials to cure severe red blood congenital diseases such as sickle cell anemia or Thalassemia by safely modifying the DNA of patients' blood cells.
The first cases treated with this approach were recently published in an article co-authored by Dr. Damiano Rondelli, the M . . .
University of Illinois Chicago is one of the U.S. sites participating in clinical trials to cure severe red blood congenital diseases such as sickle cell anemia or Thalassemia by safely modifying the DNA of patients' blood cells.
The first cases treated with this approach were recently published in an article co-authored by Dr. Damiano Rondelli, the M . . .